Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Egalet Corp (NASDAQ:EGLT)

7.23
Delayed Data
As of Dec 02
 +0.31 / +4.48%
Today’s Change
4.34
Today|||52-Week Range
11.81
-34.39%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$182.1M

Company Description

Egalet Corp. develops and manufactures pharmaceutical products. It provides pipeline of clinical stage opioid based product candidates that are specifically designed to deter abuse by physical and chemical manipulation. It includes products SPRIX nasal spray and OXAYDO tablets which are used to treat pain. The company was founded in August 2013 and is headquartered in Malvern, PA.

Contact Information

Egalet Corp.
600 Lee Road
Wayne Pennsylvania 19087
P:(610) 833-4200
Investor Relations:

Employees

Shareholders

Mutual fund holders39.14%
Individual stakeholders30.01%
Other institutional20.15%

Top Executives

Robert Samuel RadiePresident, Chief Executive Officer & Director
Mark StrobeckChief Operating Officer & Executive VP
Stanley J. MusialChief Financial Officer & Secretary
Karsten LindhardtVice President-Research & Development
Jeffrey M. DaynoChief Medical Officer